863578-19-2

Basic information

• Product Name: 2-(2-aminophenyl)-3-cyclohexyl-1H-indole-6-carboxylic acid methyl ester
• Synonyms: 2-(2-aminophenyl)-3-cyclohexyl-1H-indole-6-carboxylic acid methyl ester
• CAS NO: 863578-19-2
• Molecular Weight: 348.445
• Mol File: 863578-19-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-(2-aminophenyl)-3-cyclohexyl-1H-indole-6-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-aminophenyl)-3-cyclohexyl-1H-indole-6-carboxylic acid methyl ester(863578-19-2)
• EPA Substance Registry System: 2-(2-aminophenyl)-3-cyclohexyl-1H-indole-6-carboxylic acid methyl ester(863578-19-2)

Safety Data

• Hazardous Substances Data: 863578-19-2(Hazardous Substances Data)

Upstream product

• 615-36-1 2-bromoaniline 
• 877271-95-9 methyl 2-(2-{[(tert-butoxycarbonyl)amino]phenyl})-3-cyclohexyl-1H-indole-6-carboxylate 
• 494799-19-8 methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate 
• 191171-55-8 2-anilineboronic acid pinacol ester 

Downstream Products

• 956580-06-6 dimethyl 13-cyclohexyl-6,7-dihydro-5H-indolo[1,2-d][1,4]benzodiazepine-6,10-dicarboxylate 
• 917364-92-2 13-cyclohexyl-5-[2-oxo-2-(piperidin-1-yl)ethyl]-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 917364-90-0 13-cyclohexyl-5-(2-piperidin-1-ylethyl)-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 863567-00-4 5-tert-butoxycarbonylmethyl-13-cyclohexyl-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 917364-93-3 13-cyclohexyl-5-(2-phenylethyl)-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 917364-94-4 13-cyclohexyl-5-(dimethylcarbamoylmethyl)-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 917364-91-1 13-cyclohexyl-5-benzyl-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 863567-01-5 (13-cyclohexyl-10-methoxycarbonyl-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-5-yl)acetic acid 
• 917364-95-5 13-cyclohexyl-5-(2-dimethylaminoethyl)-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 917364-89-7 5-acetyl-13-cyclohexyl-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 863566-97-6 13-cyclohexyl-6-oxo-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 863630-58-4 13-cyclohexyl-6,7-dihydro-5H-indolo[1,2-d][1,4]benzodiazepin-10-carboxylic acid 
• 863566-98-7 13-cyclohexyl-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 
• 917364-88-6 13-cyclohexyl-5-methyl-6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indole-10-carboxylic acid methyl ester 

Relevant articles and documents

Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase

We report the evolutionary path from an open-chain series to conformationally constrained tetracyclic indole inhibitors of HCV NS5B-polymerase, where the C2 aromatic is tethered to the indole nitrogen. SAR studies led to the discovery of zwitterionic comp

PENTACYCLIC INDOLE DERIVATIVES AS ANTIVIRAL AGENTS

The present invention relates to pentacyclic indole derivatives of formula (I): wherein A, Ar, R1, R2, W, X, Y and Z are defined herein, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them, and their use for the treatment or prevention of infection by hepatitis C virus.

FUSED HETEROTETRACYCLIC COMPOUNDS AND USE TEHREOF AS HCV POLYMERASE INHIBITOR

The present invention relates to a tetracyclic fused heterocyclic compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable a salt thereof, and a hepatitis C virus (HCV) polymerase inhibitor and a therapeutic agent for hepatitis C containing this compound. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.